Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Embark Veterinary
AddedFeb 15, 2024
UpdatedJun 18, 2026
Embark Veterinary

Embark Veterinary

Series B

Embark: Comprehensive dog DNA testing and veterinary services for informed pet care.

HQ
Boston, MA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to improve the lives of dogs and their owners through advanced genetic testing, Embark Veterinary offers comprehensive dog DNA tests. Their core vision is to empower pet owners with detailed insights into their dog's breed, ancestry, and health, enabling informed care decisions. The company provides various DNA testing products, including Breed + Health Dog DNA Tests and Breed ID Dog DNA Tests, which are accessible through their online platform. Embark focuses on the pet care market, particularly targeting dog owners who seek to understand their pets better.

Notable figures associated with Embark Veterinary include co-founders Ryan and Adam Boyko, who have backgrounds in canine genetics. The company has garnered significant attention and investment from prominent venture capital firms. Key achievements include receiving over 20,000 five-star reviews and being recognized as a top gift by New York Magazine. Embark's impact is evident in the enhanced understanding and care it facilitates for dogs, contributing to the well-being of pets and peace of mind for their owners.

Embark Veterinary - Quick Facts

When was Embark Veterinary founded?

Embark Veterinary was founded in 2015.

Where is Embark Veterinary's headquarters located?

Embark Veterinary's headquarters is located in Boston, MA, US.

When was Embark Veterinary's last funding round?

Embark Veterinary's most recent funding round was for $75M (USD) in July 2021.

How much has Embark Veterinary raised to-date?

As of Jul 26, 2021, Embark Veterinary has raised a total of $94.3M (USD).

How many employees does Embark Veterinary have?

Embark Veterinary has 185 employees as of Feb 5, 2024.

Embark Veterinary - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
  • GenAI
Geographic Exposure
  • United States
Revenue
  • Transactional
Customer
  • Consumers
Main Product
  • DNA Testing
  • Pet Care
Tags
  • Biotech
  • Data
  • eCommerce
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541940Veterinary Services
  • 541000Professional, Scientific, and Technical Services
  • 541900Other Professional, Scientific, and Technical Services
SIC
  • 700Agricultural Services
  • 740Veterinary Services
Show 5 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 7300Business Services
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified